Fig. 2
From: In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis
a Aetiology of SIADH. b Primary Sites for Underlying Malignancies Associated with SIADH. *NSCLC – Non-small Cell Lung Cancer, SCLC – Small Cell Lung Cancer.